...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Journal of stroke and cerebrovascular diseases: The official journal of National Stroke Association >COVID-19 and Stroke: Incidence and Etiological Description in a High-Volume Center
【24h】

COVID-19 and Stroke: Incidence and Etiological Description in a High-Volume Center

机译：Covid-19和中风：大容量中心的发病和病因描述

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Background: An increased rate of thrombotic events has been associated to Coronavirus Disease 19 (COVID-19) with a variable rate of acute stroke. Our aim is to uncover the rate of acute stroke in COVID-19 patients and identify those cases in which a possible causative relationship could exist. Methods: We performed a single-center analysis of a prospective mandatory database. We studied all patients with confirmed COVID-19 and stroke diagnoses from March 2nd to April 30th. Demographic, clinical, and imaging data were prospectively collected. Final diagnosis was determined after full diagnostic work-up unless impossible due to death. Results: Of 2050 patients with confirmed SARS-CoV-2 infection, 21 (1.02%) presented an acute ischemic stroke 21 and 4 (0.2%) suffered an intracranial hemorrhage. After the diagnostic work-up, in 60.0% ischemic and all hemorrhagic strokes patients an etiology non-related with COVID-19 was identified. Only in 6 patients the stroke cause was considered possibly related to COVID-19, all of them required mechanical ventilation before stroke onset. Ten patients underwent endovascular treatment; compared with patients who underwent EVT in the same period, COVID-19 was an independent predictor of in-hospital mortality (50% versus 15%; Odds Ratio, 6.67; 95% CI, 1.1-40.4; p 0.04). Conclusions: The presence of acute stroke in patients with COVID-19 was below 2% and most of them previously presented established stroke risk factors. Without other potential cause, stroke was an uncommon complication and exclusive of patients with a severe pulmonary injury. The presence of COVID-19 in patients who underwent EVT was an independent predictor of in-hospital mortality.
机译：背景：血栓性事件的发生率增加与冠状病毒病19（COVID-19）相关，急性卒中的发生率可变。我们的目的是2019冠状病毒疾病患者的急性脑卒中发生率，并确定可能存在因果关系的病例。方法：我们对一个前瞻性强制性数据库进行单中心分析。我们研究了所有2019冠状病毒疾病患者和卒中诊断。前瞻性收集人口统计学、临床和影像学数据。最终诊断在全面诊断检查后确定，除非因死亡而不可能。结果：在2050例确诊SARS-CoV-2感染的患者中，21例（1.02%）出现急性缺血性卒中，21例（0.2%）出现颅内出血。在诊断2019冠状病毒疾病后，60%例缺血性脑卒中和所有出血性中风患者的病因与COVID-19无关。6例脑卒中2019冠状病毒疾病可能与脑卒中前发病有关。10例接受血管内治疗；C2019冠状病毒疾病与住院患者相比，住院死亡率（50%比15%；优势比6.67；95%可信区间，1.1-40.4；P 0.04）。结论：COV2019冠状病毒疾病患者急性卒中的发生率低于2%，且大多数患者均已出现卒中危险因素。在没有其他潜在原因的情况下，中风是一种罕见的并发症，不包括严重肺损伤的患者。COVID-2019冠状病毒疾病患者的死亡率是住院死亡率的独立预测因子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号